Investor Group Comments on Pasithea Therapeutics’ Seemingly Defensive and Dilutive Related-Party Acquisition of Alpha-5
It is clear to us that the sitting directors are more focused on entrenchment than on advancing stockholders best interests.
- It is clear to us that the sitting directors are more focused on entrenchment than on advancing stockholders best interests.
- We intend to investigate all aspects of this very troubling transaction, including for any breaches of fiduciary duty by the Board of Directors.
- We also question why a transaction in which a Pasithea director had a financial interest was not presented to stockholders for approval.
- Promptly after filing their definitive special meeting request statement with the SEC, the Participants intend to mail such statement and a WHITE special meeting request card to Pasithea stockholders.